An anti-KRAS ASO inhibits pancreatic tumor growth (IMAGE)
Caption
Compared with a control (left), treatment with an antisense oligonucleotide targeting KRAS (right) reduces the size of a pancreatic tumor cell spheroid grown in the lab.
Credit
© 2026 Marco et al. Originally published in Journal of Cell Biology. https://doi.org/10.1083/jcb.202507217
Usage Restrictions
Credit must be given to the creator.
License
CC BY